Balance Sheet

Assets

-6%

+36%

10Y

Currency: MYR

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	5	6	27	52	52	69	56	36	104	103	55	30	24	31	21	70	28	23	17	23	27	24	127	152
Cash	5	6	27	52	52	69	56	36	104	103	55	30	24	31	21	70	28	23	17	23	27	24	127	152
Short-Term Investments	2	1	0	2	1	1	0	58	0	0	0	5	9	1	1	0	0	13	12	18	25	29	78	84
Total Receivables	169	177	201	213	295	267	307	192	166	144	216	208	159	124	182	237	251	309	262	282	272	339	370	425
Accounts Receivables	164	167	195	195	267	247	295	178	146	124	204	200	144	117	148	161	165	223	204	237	228	262	285	338
Other Receivables	4	9	5	17	29	21	12	14	20	20	12	8	16	7	34	76	86	87	58	45	44	77	84	87
Inventory	71	101	109	128	162	172	182	162	228	230	385	465	411	427	540	532	485	693	618	587	1 264	767	581	613
Other Current Assets	0	0	0	0	0	0	34	47	0	0	14	16	23	22	25	37	14	20	24	16	33	36	30	15
Total Current Assets	247	284	337	396	510	509	580	495	498	477	670	723	626	604	769	877	779	1 059	934	926	1 621	1 195	1 107	1 204
PP&E Net	136	164	192	214	252	276	241	258	278	277	346	340	353	370	406	420	411	406	410	398	396	443	606	609
PP&E Gross	136	164	192	214	252	276	241	258	278	277	346	340	0	370	406	420	411	406	410	398	396	443	606	609
Accumulated Depreciation	43	61	81	105	124	112	107	104	116	128	163	192	0	255	278	307	330	353	375	398	436	464	543	570
Intangible Assets	8	5	4	3	3	34	2	5	3	3	18	67	47	106	151	202	232	269	68	74	79	83	72	74
Goodwill	0	16	15	17	32	0	32	31	29	29	87	82	77	127	133	141	133	131	133	131	129	77	77	77
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	12	15	0	0	0	0	0	0	0
Long-Term Investments	0	0	1	0	0	7	6	7	7	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	0	0	0	0	2	2	24	2	4	11	12	10	8	24	27	31	38	42	48	50	33	49	52	27
Other Assets	0	16	15	17	32	0	32	31	29	29	87	82	77	127	133	141	133	131	133	131	129	77	77	77
Total Assets	391 N/A	468 +20%	549 +17%	629 +15%	798 +27%	828 +4%	885 +7%	798 -10%	818 +2%	802 -2%	1 134 +41%	1 223 +8%	1 111 -9%	1 243 +12%	1 496 +20%	1 683 +13%	1 608 -4%	1 908 +19%	1 592 -17%	1 580 -1%	2 258 +43%	1 847 -18%	1 915 +4%	1 992 +4%
Liabilities
Accounts Payable	127	160	174	232	272	239	290	270	289	318	416	309	339	398	437	378	499	572	549	442	678	648	628	650
Accrued Liabilities	0	0	0	0	0	0	0	0	8	7	25	25	26	25	13	9	16	21	0	18	25	38	33	33
Short-Term Debt	0	0	0	0	0	0	0	0	39	33	188	341	0	0	0	0	284	392	415	439	544	681	711	771
Current Portion of Long-Term Debt	40	56	76	38	106	165	166	96	20	0	0	0	200	200	400	617	160	250	152	232	27	390	340	288
Other Current Liabilities	10	0	3	6	3	2	4	1	4	2	12	49	25	32	44	58	33	71	85	64	193	310	290	210
Total Current Liabilities	177	217	253	276	380	406	460	367	359	360	641	724	590	655	894	1 062	993	1 307	1 201	1 194	1 468	2 068	2 002	1 953
Long-Term Debt	11	9	5	0	87	91	59	26	7	0	0	0	0	1	1	0	0	0	2	1	286	97	140	133
Deferred Income Tax	2	2	2	2	4	4	4	3	3	2	5	5	13	28	33	48	53	59	18	16	21	19	33	27
Minority Interest	33	39	46	67	10	11	13	14	16	16	14	16	16	26	31	29	19	19	19	17	20	21	25	25
Other Liabilities	0	0	0	0	0	0	0	0	2	3	4	6	5	6	8	13	14	13	14	14	13	12	14	25
Total Liabilities	223 N/A	267 +20%	307 +15%	345 +12%	480 +39%	512 +7%	535 +5%	410 -23%	388 -6%	380 -2%	665 +75%	751 +13%	623 -17%	716 +15%	966 +35%	1 152 +19%	1 080 -6%	1 398 +30%	1 254 -10%	1 243 -1%	1 807 +45%	2 217 +23%	2 214 0%	2 164 -2%
Equity
Common Stock	50	100	101	102	107	107	107	107	107	107	107	118	129	129	129	130	146	149	152	153	154	154	200	200
Retained Earnings	119	101	139	177	189	188	224	265	304	296	342	344	351	387	380	366	368	351	175	182	294	525	603	471
Additional Paid In Capital	0	0	2	6	22	22	22	22	22	22	22	12	12	12	12	20	11	8	7	2	2	4	4	4
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	101	101
Other Equity	0	0	0	0	1	1	4	7	2	4	2	1	4	2	8	15	3	1	3	0	1	2	0	4
Total Equity	169 N/A	201 +19%	242 +20%	285 +18%	318 +12%	316 0%	350 +11%	388 +11%	431 +11%	422 -2%	469 +11%	472 +1%	488 +3%	527 +8%	529 +1%	531 +0%	528 0%	509 -4%	338 -34%	338 0%	450 +33%	370 N/A	299 +19%	171 +43%
Total Liabilities & Equity	391 N/A	468 +20%	549 +17%	629 +15%	798 +27%	828 +4%	885 +7%	798 -10%	818 +2%	802 -2%	1 134 +41%	1 223 +8%	1 111 -9%	1 243 +12%	1 496 +20%	1 683 +13%	1 608 -4%	1 908 +19%	1 592 -17%	1 580 -1%	2 258 +43%	1 847 -18%	1 915 +4%	1 992 +4%
Shares Outstanding
Common Shares Outstanding	242	242	243	247	259	259	259	259	259	259	259	259	259	259	259	1 297	1 299	1 303	1 306	1 309	1 310	2 204	2 424	2 424

Income Statement Balance Sheet Cash Flow Statement

Pharmaniaga Bhd
KLSE:PHARMA

Balance Sheet

Balance Sheet Decomposition
Pharmaniaga Bhd

Balance Sheet
Pharmaniaga Bhd

See Also

Company

Help

Tools

Stocks

Pharmaniaga Bhd KLSE:PHARMA

Balance Sheet

Balance Sheet Decomposition Pharmaniaga Bhd

Balance Sheet Pharmaniaga Bhd

See Also

Company

Help

Tools

Stocks

Pharmaniaga Bhd
KLSE:PHARMA

Balance Sheet Decomposition
Pharmaniaga Bhd

Balance Sheet
Pharmaniaga Bhd